Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPI1 | P60174 | 2/20 | 0.48 |
| ▸ | PGK1 | P00558 | 1/20 | 0.41 |
| ▸ | PGK2 | P07205 | 1/20 | 0.41 |
| ▸ | PGD | P52209 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | CTH | P32929 | 1/20 | 0.36 |
| ▸ | CBS | P35520 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MVD | P53602 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoglycolic Acid SCHEMBL380471 | 0.92 | — | — | |
| Phosphoglycolic Acid SCHEMBL20798069 | 0.92 | TPI1 (0.54) | TPI1PGK1PGK2PGDTSHR | |
| Phosphoglycolic Acid SCHEMBL29156120 | 0.90 | TPI1 (0.52) | TPI1PGK1PGK2PGDTSHR | |
| Phosphoglycolic Acid SCHEMBL5586781 | 0.90 | TPI1 (0.52) | TPI1PGK1PGK2PGDTSHR | |
| Phosphoglycolic Acid SCHEMBL9172688 | 0.87 | TPI1 (0.50) | TPI1PGK1PGK2PGDTSHR | |
| Phosphoglycolic Acid SCHEMBL27464510 | 0.87 | TPI1 (0.50) | TPI1PGK1PGK2PGDTSHR | |
| SCHEMBL8852887 | 0.76 | MVD (0.42) | TPI1PGK1PGK2PGDTSHR | |
| 3-Phosphoglyceric Acid SCHEMBL8006738 | 0.74 | PGK1 (0.81) | TPI1PGK1PGK2PGD | |
| Phosphoglycolic Acid SCHEMBL19253821 | 0.74 | TPI1 (0.39) | TPI1PGK1PGK2PGDTDP1 | |
| SCHEMBL5485133 | 0.73 | TPI1 (0.56) | TPI1PGK1PGK2PGDBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1506786-B1 | MEDICINAL COMPOSITIONS CONTAINING GHRELIN | DAIICHI SANKYO CO LTD (JP) | 2016-11-23 | — | — | EP | claimed |
| US-8518893-B2 | Medical compositions containing ghrelin | ASUBIO PHARMA CO. LTD. (JP) | 2013-08-27 | — | — | US | claimed |
| US-8440628-B2 | stable aqueous solution containing endogenous growth hormone secretagogues having pH range of 2 to 7; a pH adjuster or a buffer agent; nondegradation, storage stability; biodrug inducing the secretion of growth hormone | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-05-14 | — | — | US | claimed |
| US-20120264691-A1 | MEDICAL COMPOSITIONS CONTAINING GHRELIN | KENJI KANGAWA (JP) | 2012-10-18 | — | — | US | claimed |
| CN-100411683-C | Medicinal compositions containing ghrelin | DAIICHI SUNTORY PHARMA CO LTD (JP) | 2008-08-20 | — | — | CN | claimed |
| US-20080081787-A1 | Medical compositions containing ghrelin | Kangawa, Kenji (JP) | 2008-04-03 | — | — | US | claimed |
| US-20060166871-A1 | Medical compositions containing ghrelin | DAIICHI SUNTORY PHARMA., LTD. (JP) | 2006-07-27 | — | — | US | claimed |
| CN-1622822-A | Medicinal compositions containing ghrelin | DAIICHI SUNTORY PHARMA CO LTD (JP) | 2005-06-01 | — | — | CN | claimed |
| EP-1506786-A1 | MEDICINAL COMPOSITIONS CONTAINING GHRELIN | Daiichi Suntory Pharma Co., Ltd. (JP) | 2005-02-16 | — | — | EP | claimed |
| US-20040110845-A1 | Stabilized albuterol compositions and method of preparation thereof | DEY, L.P. | 2004-06-10 | — | — | US | claimed |
| US-20040109826-A1 | Stabilized albuterol compositions and method of preparation thereof | DEY, L.P. | 2004-06-10 | — | — | US | claimed |
| US-11931422-B2 | Antibody-urease conjugates for therapeutic purposes | HELIX BIOPHARMA CORPORATION (CA) | 2024-03-19 | — | — | US | disclosed |
| EP-3261678-B1 | ANTIBODY-UREASE CONJUGATES FOR THERAPEUTIC PURPOSES | HELIX BIOPHARMA CORP (CA) | 2020-11-11 | — | — | EP | disclosed |
| US-20200261541-A1 | METHODS OF TREATING MILD BRAIN INJURY | OXEIA BIOPHARMACEUTICALS, INC. (US) | 2020-08-20 | — | — | US | disclosed |
| CN-110382551-A | Anti-VEGFR-2 urase conjugate | 赫利克斯生物药品公司 | 2019-10-25 | — | — | CN | disclosed |
| EP-1506786-A1 | MEDICINAL COMPOSITIONS CONTAINING GHRELIN | Daiichi Suntory Pharma Co., Ltd. (JP) | 2005-02-16 | — | — | EP | disclosed |
| EP-1506786-A1 | MEDICINAL COMPOSITIONS CONTAINING GHRELIN | Daiichi Suntory Pharma Co., Ltd. (JP) | 2005-02-16 | — | — | EP | disclosed |
| US-20040110845-A1 | Stabilized albuterol compositions and method of preparation thereof | DEY, L.P. | 2004-06-10 | — | — | US | disclosed |
| US-20040109826-A1 | Stabilized albuterol compositions and method of preparation thereof | DEY, L.P. | 2004-06-10 | — | — | US | disclosed |
| WO-2003097083-A1 | MEDICINAL COMPOSITIONS CONTAINING GHRELIN | DAIICHI SUNTORY PHARMA CO.,LTD. (JP) | 2003-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200261541-A1 | METHODS OF TREATING MILD BRAIN INJURY | FABP7, PYGB, ATP6V1B2 | TPI1 4596/4885PGK1 1901/4885PGK2 1769/4885 |
| US-11931422-B2 | Antibody-urease conjugates for therapeutic purposes | SLC14A1, UNG, UPP1 | TPI1 775/4885PGK1 3225/4885PGK2 3035/4885 |
| US-20040110845-A1 | Stabilized albuterol compositions and method of preparation thereof | ALB, CMA1, ADRB2 | TPI1 2776/4885PGK1 2440/4885PGK2 2475/4885 |
| US-20040109826-A1 | Stabilized albuterol compositions and method of preparation thereof | ALB, CMA1, ADRB2 | TPI1 2776/4885PGK1 2440/4885PGK2 2475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.